HIV and Metabolic, Body, and Bone Disorders: What We Know From Low- and Middle-Income Countries

@article{Ali2014HIVAM,
  title={HIV and Metabolic, Body, and Bone Disorders: What We Know From Low- and Middle-Income Countries},
  author={Mohammed K. Ali and Matthew J Magee and Joel A Dave and Ighovwhera Ofotokun and Marisa Tungsiripat and Trammell K Jones and Naomi S Levitt and David Rimland and Wendy S Armstrong},
  journal={JAIDS Journal of Acquired Immune Deficiency Syndromes},
  year={2014},
  volume={67},
  pages={S27–S39}
}
Abstract:Globally, the HIV epidemic is evolving. Life expectancy for HIV-infected individuals has been extended because of more effective and more widely available antiretroviral therapy. As a result, chronic noncommunicable diseases (NCDs) have become important comorbid conditions. In particular, HIV-infected persons are increasingly at risk of developing metabolic (diabetes, dyslipidemias), body composition (lipodystrophy, overweight/obesity) and bone mineral density abnormalities. We have… 
View on Wolters Kluwer
journals.lww.com
52 Citations
Highly Influential Citations
6
Background Citations
18
Results Citations
2

52 Citations

HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART Era: What We Know and Best Directions for Future Research

Evidence-linking HIV infection to the most commonly cited chronic cardiovascular and pulmonary conditions in LMICs: heart failure, hypertension, coronary artery disease/myocardial infarction, stroke, obstructive lung diseases, and pulmonary arterial hypertension is summarized.

HIV/AIDS Comorbidities: Impact on Cancer, Noncommunicable Diseases, and Reproductive Health

The data from many parts of the world clearly show that despite the dramatic decrease in deaths due to HIV with the continued expansion of access to successful treatment, access to ART alone will not prevent, and in some cases may precipitate, a wide spectrum of complications of long-term HIV infection.

Noncommunicable Diseases in HIV Infection in Low- and Middle-Income Countries: Gastrointestinal, Hepatic, and Nutritional Aspects

Across the spectrum of GI, hepatic, and nutritional disorders in HIV infection, there is increasing evidence that the microbiome may play an important role in disease pathogenesis, but work in this area, especially in low- and middle-income countries, is in its infancy.

Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy

In this Hispanic cohort in an LMIC, incidences of IFG/DM and overweight/obesity were similar to or higher than that found in high income countries, and cardiometabolic disorders affected three-quarters of those initiating ART.

Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients

Participants on ART had higher TG, TC, LDLC and HDLC than those who were ART-naïve but severe lipid abnormalities requiring evaluation and treatment were uncommon.

Dysglycemia associations with adipose tissue among HIV-infected patients after 2 years of antiretroviral therapy in Mwanza: a follow-up cross-sectional study

Low rather than high measures of adipose tissue were associated with increased risk of pre-diabetes and diabetes and the role of body composition and control of glucose metabolism in the pathogenesis of diabetes among persons living with HIV in Africa is investigated.

Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults

HIV-infected adults on long-term ART had 5-fold greater odds of glucose metabolism disorders than HIV-negative controls but were rarely aware of their diagnosis, and were significantly associated with higher CD4+ T-cell counts.

HIV and Noncommunicable Diseases: The Asian Perspective

Asia is seeing a rise in noncommunicable diseases in their general population and among people living with HIV, and Asia has not only the highest burden of hepatitis B viral infection than any other continent but also a predominance of genotypes B and C, the latter associated with higher risk for hepatocellular carcinoma.

Alterations of Glucose Metabolism in HIV-Infected Patients

  • M. I. Luna
  • Medicine, Biology
    Current Tropical Medicine Reports
  • 2018
HIV-infected patients should be considered at high risk for alterations of glucose metabolism, including insulin resistance, pre-diabetes, and diabetes, especially after initiating ART, and treatment remains similar to the general population.

Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis

Improved data collection and surveillance of NCDs among PLHIV in LMICs are necessary to inform integrated HIV/NCD care models, and further research is needed to optimize the efficacy of these programs.
...

References

SHOWING 1-10 OF 134 REFERENCES

HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART Era: What We Know and Best Directions for Future Research

Evidence-linking HIV infection to the most commonly cited chronic cardiovascular and pulmonary conditions in LMICs: heart failure, hypertension, coronary artery disease/myocardial infarction, stroke, obstructive lung diseases, and pulmonary arterial hypertension is summarized.

Lipid Abnormalities in a Never-Treated HIV-1 Subtype C-Infected African Population

It is shown that HIV-1 subtype C is associated with dyslipidemia, but not with a higher incidence of MetS in never antiretroviral-treated HIV-infected Africans.

HIV-Associated Renal and Genitourinary Comorbidities in Africa

The epidemiology of HIV-associated renal and urogenital diseases, including interactions with kidney-related NCDs such as hypertension, diabetes mellitus, and cardiovascular disease are reviewed, and the current evidence regarding the impact of HIV infection on the development of urogensital diseases is examined.

Cardiovascular implications of HIV-induced dyslipidemia.

Lipodystrophy and Metabolic Disorders in HIV-1-Infected Adults on 4- to 9-Year Antiretroviral Therapy in Senegal: A Case-Control Study

Moderate-severe lipodystrophy affected one third of West African patients on long-term HAART and was associated with a less favorable metabolic profile.

Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART.

  • P. CahnO. Leite T. Suffert
  • Medicine
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
  • 2010

HIV Infection and Obesity: Where Did All the Wasting Go?

The findings that almost half of patients were overweight or obese at ART initiation, and 1 in 5 patients moved to a deleterious BMI category within 2 years of ART initiation are alarming.

HIV and low bone density: Responsible party, or guilty by association?

The available clinical evidence suggests that BMD is stable or improves in HIV-infected people receiving long-term combination anti-retroviral therapy (originally termed HAART), and that if fracture risk is increased, it is largely attributable to a higher prevalence of classical risk factors for low BMD and fracture.

Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.

The causes of low bone mineral density in HIV-infected persons, including the impact of specific antiretroviral therapies, are discussed, and recommendations on screening and treating vitamin D deficiency and osteoporosis are offered.

Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy

Cumulative NRTI therapy wasassociated with longitudinal decreases in body circumference measurements, whereas HIV-serostatus was associated with increases in waist circumference independent of ART.
...